Medical Oncology

, 31:61 | Cite as

Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer

  • Xiao-tian Ye
  • Ai-jun Guo
  • Peng-fei Yin
  • Xian-dong Cao
  • Jia-cong ChangEmail author
Original Paper


Novel (nua) kinase family 1 (NUAK1) is a member of the human adenosine monophosphate-activated protein kinases family, which is overexpressed in multiple human malignancies and thought to be involved in tumor invasion and metastasis ability. Our study is to investigate the association of NUAK1 expression with clinicopathological parameters and prognostic significance of patients with gastric cancer. The expression patterns of the NUAK1 protein in 117 primary archival gastric cancer specimens and 46 adjacent normal epithelial tissues from patients were detected by immunohistochemistry assay. Staining evaluation results were analyzed statistically in relation to various clinicopathological characters, recurrence-free survival and overall survival. High level of NUAK1 expression was detected in gastric cancer, significantly more than in adjacent normal epithelial cells. In gastric cancer, NUAK1 was positively correlated with depth of invasion, lymph node metastasis, pathological stage, surgical resection and histological differentiation. However, no correlations between NUAK1 expression and patients’ age, sex, tumor size, location, CA19-9 or CEA were detected. The recurrence-free survival and overall survival were significantly shorter for patients with NUAK1 higher scores than those with NUAK1 lower scores. Multivariate analysis identified NUAK1 was an independent prognostic factor for both recurrence-free survival and overall survival. Our findings provided convincing evidence for NUAK1 overexpression, which was tightly associated with more aggressive tumor behavior and a poor prognosis, indicating that NUAK1 is a valuable molecular biomarker for gastric cancer progression. It might also act as a promising target for both prognostic prediction and therapeutics.


NUAK1 Gastric cancer Biomarker Prognosis 



This study was funded by Key Programs of Educational Commission of Anhui Province (No. KJ2010A181) and Medical Scientific Research Foundation of Anhui Province, China (No. 09A034).

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46(4):765–81. doi: 10.1016/j.ejca.2009.12.014.PubMedCrossRefGoogle Scholar
  2. 2.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi: 10.3322/caac.20107.PubMedCrossRefGoogle Scholar
  3. 3.
    Bernal C, Aguayo F, Villarroel C, Vargas M, Diaz I, Ossandon FJ, et al. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res. 2008;14(19):6264–9. doi: 10.1158/1078-0432.CCR-07-4522.PubMedCrossRefGoogle Scholar
  4. 4.
    Marrelli D, Roviello F, De Stefano A, Farnetani M, Garosi L, Messano A, et al. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology. 1999;57(1):55–62.PubMedCrossRefGoogle Scholar
  5. 5.
    Suzuki A, Kusakai G, Kishimoto A, Shimojo Y, Miyamoto S, Ogura T, et al. Regulation of caspase-6 and FLIP by the AMPK family member ARK5. Oncogene. 2004;23(42):7067–75. doi: 10.1038/sj.onc.1207963.PubMedCrossRefGoogle Scholar
  6. 6.
    Kusakai G, Suzuki A, Ogura T, Miyamoto S, Ochiai A, Kaminishi M, et al. ARK5 expression in colorectal cancer and its implications for tumor progression. Am J Pathol. 2004;164(3):987–95.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Chen P, Li K, Liang Y, Li L, Zhu X. High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion. Exp Lung Res. 2013;39(1):9–17. doi: 10.3109/01902148.2012.744115.PubMedCrossRefGoogle Scholar
  8. 8.
    Lu S, Niu N, Guo H, Tang J, Guo W, Liu Z, et al. ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome. Eur J Cancer. 2013;49(3):752–63. doi: 10.1016/j.ejca.2012.09.018.PubMedCrossRefGoogle Scholar
  9. 9.
    Kinoshita R, Iwadate M, Umeyama H, Taguchi YH. Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets. BMC Syst Biol. 2014;8(Suppl 1):S4. doi: 10.1186/1752-0509-8-S1-S4.PubMedCrossRefGoogle Scholar
  10. 10.
    Cui J, Yu Y, Lu GF, Liu C, Liu X, Xu YX, et al. Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma. Tumour Biol. 2013;34(3):1913–8. doi: 10.1007/s13277-013-0735-x.PubMedCrossRefGoogle Scholar
  11. 11.
    Ye YZ, Zhang ZH, Fan XY, Xu XL, Chen ML, Chang BW, et al. Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer. Med Oncol. 2013;30(2):595. doi: 10.1007/s12032-013-0595-7.PubMedCrossRefGoogle Scholar
  12. 12.
    Cheng WL, Wang CS, Huang YH, Liang Y, Lin PY, Hsueh C, et al. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer. 2008;123(8):1787–96. doi: 10.1002/ijc.23746.PubMedCrossRefGoogle Scholar
  13. 13.
    Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12(1):17–20.PubMedGoogle Scholar
  14. 14.
    Hardie DG, Alessi DR. LKB1 and AMPK and the cancer-metabolism link: ten years after. BMC Biol. 2013;11:36. doi: 10.1186/1741-7007-11-36.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Sun X, Gao L, Chien HY, Li WC, Zhao J. The regulation and function of the NUAK family. J Mol Endocrinol. 2013;51(2):R15–22. doi: 10.1530/JME-13-0063.PubMedCrossRefGoogle Scholar
  16. 16.
    Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF, et al. Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J Biol Chem. 2003;278(1):48–53. doi: 10.1074/jbc.M206025200.PubMedCrossRefGoogle Scholar
  17. 17.
    Koh HJ, Toyoda T, Fujii N, Jung MM, Rathod A, Middelbeek RJ, et al. Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle. Proc Natl Acad Sci USA. 2010;107(35):15541–6. doi: 10.1073/pnas.1008131107.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Hou X, Liu JE, Liu W, Liu CY, Liu ZY, Sun ZY. A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation. Oncogene. 2011;30(26):2933–42. doi: 10.1038/onc.2011.19.PubMedCrossRefGoogle Scholar
  19. 19.
    Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T, Esumi H. ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol Cell Biol. 2004;24(8):3526–35.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Humbert N, Navaratnam N, Augert A, Da Costa M, Martien S, Wang J, et al. Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. EMBO J. 2010;29(2):376–86. doi: 10.1038/emboj.2009.342.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Liu L, Ulbrich J, Muller J, Wustefeld T, Aeberhard L, Kress TR, et al. Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature. 2012;483(7391):608–12. doi: 10.1038/nature10927.PubMedCrossRefGoogle Scholar
  22. 22.
    Kochi M, Fujii M, Kanamori N, Kaiga T, Kawakami T, Aizaki K, et al. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer. 2000;3(4):177–86.PubMedCrossRefGoogle Scholar
  23. 23.
    Chu D, Zhang Z, Li Y, Zheng J, Dong G, Wang W, et al. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Int J Cancer. 2011;129(4):887–95. doi: 10.1002/ijc.25734.PubMedCrossRefGoogle Scholar
  24. 24.
    Ying J, Xu Q, Zhang G, Liu B, Zhu L. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med Oncol. 2012;29(3):1716–22. doi: 10.1007/s12032-011-9990-0.PubMedCrossRefGoogle Scholar
  25. 25.
    Chen W, Wang J, Li X, Li J, Zhou L, Qiu T, et al. Prognostic significance of BRCA1 expression in gastric cancer. Med Oncol. 2013;30(1):423. doi: 10.1007/s12032-012-0423-5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Xiao-tian Ye
    • 1
  • Ai-jun Guo
    • 1
  • Peng-fei Yin
    • 1
  • Xian-dong Cao
    • 1
  • Jia-cong Chang
    • 1
    Email author
  1. 1.Department of General SurgeryThe First Affiliated Hospital of Anhui Medical UniversityHefeiPeople’s Republic of China

Personalised recommendations